The CEO of the American pharmaceutical company stated that the production of Moderne Inc.’s covida-19 vaccine is unlikely to accelerate significantly in the next few months, adding that production is expected to increase significantly in 2022.
After temporarily suspending the Johnson & Johnson vaccine, the US government called on Moderna to speed up the production and delivery of the vaccine because six women developed rare blood clots after being vaccinated.
Hyundai CEO Stephane Bancel said in a meeting with investors: “It takes time to add new production capacity.”
He added that it can still be expected that the recently announced investment in capacity expansion will “very specifically” contribute to production growth in 2022.
Bansell stated that Moderna is still expected to produce and distribute the 700 million to 1 billion doses of vaccine planned for 2021.
Moderna announced earlier this month that it is expected to achieve its goal of delivering vaccines to European countries, which have also temporarily stopped the Johnson & Johnson vaccine.